Sussex Partner Formulary
About The Formulary
Using The Formulary
Therapeutic Sections
1 Gastro-intestinal system
2 Cardiovascular system
3 Respiratory system
4 Nervous system
5 Infection
6 Endocrine system
7 Genito-urinary system
8 Immune system & malignant disease
9 Blood and nutrition
10 Musculoskeletal system
11 Eye
12 Ear, nose and oropharynx
13 Skin
14 Vaccines
15 Anaesthesia
16 Emergency treatment of poisoning
Appendix 1 - Borderline substances
Appendix 2 - Wound management products and elasticated garments
Appendix 3 - Continence
Appendix 4 - Palliative care
Drug Index
Antimicrobial Guidance
Shared Care Protocols
Not Recommended Items
Latest APC Summary
Discontinuations
Contact us
About The Formulary
Using The Formulary
Therapeutic Sections
1 Gastro-intestinal system
2 Cardiovascular system
3 Respiratory system
4 Nervous system
5 Infection
6 Endocrine system
7 Genito-urinary system
8 Immune system & malignant disease
9 Blood and nutrition
Blood and blood-forming organs
9.1 Anaemias
9.2 Iron overload
9.3 Neutropenia and stem cell mobilisation
9.3.1 Neutropenia
9.3.2 Stem cell mobilisation
9.4 Platelet disorders
Nutrition and metabolic disorders
9.5 Fluid and electrolyte imbalances
9.6 Metabolic disorders
9.7 Mineral and trace elements deficiencies
9.8 Nutrition (intravenous)
9.9 Nutrition (oral)
9.10 Vitamin deficiency
9.11 Other Blood and nutrition items
10 Musculoskeletal system
11 Eye
12 Ear, nose and oropharynx
13 Skin
14 Vaccines
15 Anaesthesia
16 Emergency treatment of poisoning
Appendix 1 - Borderline substances
Appendix 2 - Wound management products and elasticated garments
Appendix 3 - Continence
Appendix 4 - Palliative care
Drug Index
Antimicrobial Guidance
Shared Care Protocols
Not Recommended Items
Latest APC Summary
Discontinuations
Contact us
Search
Drug Status Key
Non-Specialist Drugs
Specialist recommendation (or initiation where noted)
Specialist Initiation WITH Shared Care Guidelines
Specialist ONLY Drugs
Mixed Status - See individual drug entries for more details
Preferences
First Line
Second Line
Third Line
No Preference
Plerixafor
Funded by NHSE.
Mozobil is a branded option commissioned for prescribing.
Plerixafor 24mg/1.2ml solution for injection vials
Pack
1 vial